Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|June 14, 2025
A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytesChen Yang, Ping Wang, Mingjun Yang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2025
Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapyZhixiong Zhu, Shuqin Cao, Hanwen Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 16, 2024
mRNA-Engineered CD5-CAR-γδTCD5- Cells for the Immunotherapy of T-Cell Acute Lymphoblastic LeukemiaZhixiong Zhu, Hexian Li, Qizhong Lu, et al.
Biomolecules|December 23, 2022
Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of CraniopharyngiomaMei Tang, Caili Chen, Guoqing Wang, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myelomaJia Li, Qizhong Lu, Zhixiong Zhu, et al.
Journal of Nanobiotechnology|January 30, 2021
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike proteinQizhong Lu, Zongliang Zhang, Hexian Li, et al.
Journal of Translational Medicine|January 12, 2023
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacyZongliang Zhang, Guoqing Wang, Kunhong Zhong, et al.
Cancer Letters|March 1, 2024
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAbZongliang Zhang, Nian Yang, Huaqing Lu, et al.
Pageof 5